×
Back to Agenda
Harmonizing Regulatory Science Through the International Council for Harmonization (ICH)
Session Chair(s)
Camille Jackson
Director, Regulatory Policy; Legal and Regulatory, Flatiron Health , United States
This session will provide an overview of the ICH Association and offer insight into strategic, long-term views on advancing global convergence of regulatory science through ICH.
Learning Objective : Identify the value and benefits of global regulatory harmonization and the ICH; Discuss opportunities to advance regulatory science through ICH; Describe the current harmonization initiatives that are currently underway and the impact on global drug development.
Speaker(s)
Theresa Mullin, PhD
Associate Center Director - CDER, FDA, United States
FDA Update
Agnès Saint-Raymond, DrMed
Head of Division International Affairs, European Medicines Agency, Netherlands
EMA Update
Naoyuki Yasuda, MS
Chief Secretary for International Affairs, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
MHLW Update
Have an account?